On Queen Street: Pharma group’s new president shifts industry narrative
Photo courtesy of Innovative Medicines Canada
Innovative Medicines Canada new president Pamela Fralick joined the pharmaceutical industry group in December 2016 after 15 years in the non-profit health sector.
This content is available to lobbymonitor.ca subscribers.
Already a subscriber?
Sign in here
The Lobby Monitor community is passionate, plugged-in and engaged in Canadian politics and policy.
Come inside the bubble. Take a free trial today.
Free Trial
